These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 17996510)

  • 1. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.
    Arca M; Montali A; Valiante S; Campagna F; Pigna G; Paoletti V; Antonini R; Barillà F; Tanzilli G; Vestri A; Gaudio C
    Am J Cardiol; 2007 Nov; 100(10):1511-6. PubMed ID: 17996510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study.
    Valensi P; Avignon A; Sultan A; Chanu B; Nguyen MT; Cosson E
    Cardiovasc Diabetol; 2016 Jul; 15(1):104. PubMed ID: 27450534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients.
    Sirimarco G; Labreuche J; Bruckert E; Goldstein LB; Fox KM; Rothwell PM; Amarenco P;
    Stroke; 2014 May; 45(5):1429-36. PubMed ID: 24736236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.
    Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG
    Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Atherogenic Index of Plasma: A Powerful and Reliable Predictor for Coronary Artery Disease in Patients With Type 2 Diabetes.
    Zhou K; Qin Z; Tian J; Cui K; Yan Y; Lyu S
    Angiology; 2021 Nov; 72(10):934-941. PubMed ID: 33949211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Paradoxical Decrease in High-density Lipoprotein Cholesterol Levels After Statin Therapy on Major Adverse Cardiovascular Events in Patients with Stable Angina Pectoris.
    Hirayama K; Ota T; Harada K; Shibata Y; Tatami Y; Harata S; Kawashima K; Kunimura A; Shimbo Y; Takayama Y; Kawamiya T; Yamamoto D; Osugi N; Suzuki S; Ishii H; Murohara T
    Clin Ther; 2017 Feb; 39(2):279-287. PubMed ID: 28034517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride and Triglyceride/ HDL (High Density Lipoprotein) Ratio Predict Major Adverse Cardiovascular Outcomes in Women With Non-Obstructive Coronary Artery Disease.
    Prasad M; Sara J; Widmer RJ; Lennon R; Lerman LO; Lerman A
    J Am Heart Assoc; 2019 May; 8(9):e009442. PubMed ID: 31014162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
    Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
    Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol Control for Subclinical Coronary Atherosclerosis in Subjects Without Indication for Statin Therapy.
    Park HW; Kim YG; Park GM; Park S; Cho YR; Suh J; Lee Y; Yang DH; Kang JW; Kim HK; Choe J; Kim YH; Lee SW
    Am J Cardiol; 2021 Aug; 153():51-57. PubMed ID: 34176598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherogenic dyslipidemia in patients with transient ischemic attack.
    Sirimarco G; Deplanque D; Lavallée PC; Labreuche J; Meseguer E; Cabrejo L; Guidoux C; Olivot JM; Abboud H; Lapergue B; Klein IF; Mazighi M; Touboul PJ; Bruckert E; Amarenco P
    Stroke; 2011 Aug; 42(8):2131-7. PubMed ID: 21737806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.
    Schwartz GG; Abt M; Bao W; DeMicco D; Kallend D; Miller M; Mundl H; Olsson AG
    J Am Coll Cardiol; 2015 Jun; 65(21):2267-75. PubMed ID: 26022813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk Patients.
    Sultani R; Tong DC; Peverelle M; Lee YS; Baradi A; Wilson AM
    Heart Lung Circ; 2020 Mar; 29(3):414-421. PubMed ID: 31014557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis.
    Martin SS; Blaha MJ; Blankstein R; Agatston A; Rivera JJ; Virani SS; Ouyang P; Jones SR; Blumenthal RS; Budoff MJ; Nasir K
    Circulation; 2014 Jan; 129(1):77-86. PubMed ID: 24141324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study.
    Dai W; Zhang Z; Zhao S
    Lipids Health Dis; 2018 Dec; 17(1):273. PubMed ID: 30509306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherogenic dyslipidemia in patients with established coronary artery disease.
    Lahoz C; Mostaza JM; Tranche S; Martin-Jadraque R; Mantilla MT; López-Rodriguez I; Monteiro B; Sanchez-Zamorano MA; Taboada M
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):103-8. PubMed ID: 20675108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of nonfasting triglycerides/high-density lipoprotein cholesterol ratio on secondary prevention in patients treated with statins.
    Matsumoto I; Misaki A; Kurozumi M; Nanba T; Takagi Y
    J Cardiol; 2018 Jan; 71(1):10-15. PubMed ID: 28916255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.